Study Of Yttrium-Ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00038623 Information provided by M.D. Anderson Cancer Center

First Received: June 3, 2002 Last Updated: February 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)